In a recent trial, medical students who were trained for two hours or less in an ultrasound “volume sweep” imaging (VSI) protocol obtained diagnostic-quality imaging of palpable breast lesions.

CMS has released its highly anticipated tentative rule for governing the 2023 Medicare Physician Fee Schedule (MPFS). In turn, the American College of Radiology has posted a first-look summary focused on the schedule’s implications for medical imaging.  

The shortage of iodinated contrast media that has rattled U.S. radiology since early May didn’t come from nowhere.

The FDA is notifying patients and referrers of another breast-imaging service’s slide into noncompliance with regulatory standards for image quality.

A clinical trial pitting MRI against a burgeoning PET/CT technique has found the de facto defending champion better at revealing the presence of any grade of prostate cancer.

Two emerging MRI techniques show promise as all-in-one imaging tests for patients with pain in and below the lower back due to changes in the sacroiliac joint.

An imaging OEM is teaming with a multi-omics diagnostics company to offer lung-cancer care teams lab data alongside radiologic findings and clinical histories.

One of the largest private health insurers in the U.S. has gone from considering hybrid PET/CT for cardiac indications “experimental/investigational” to displaying willingness to pay for the modality.